Estimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 14 08 2018
revised: 05 02 2019
accepted: 06 02 2019
pubmed: 3 3 2019
medline: 11 2 2020
entrez: 3 3 2019
Statut: ppublish

Résumé

Mathematical models are increasingly being used to compare strategies for tuberculosis (TB) control and inform policy decisions. Models often do not consider financial and other constraints on implementation and may overestimate the impact that can be achieved. We developed a pragmatic approach for incorporating resource constraints into mathematical models of TB. Using a TB transmission model calibrated for South Africa, we estimated the epidemiologic impact and resource requirements (financial, human resource (HR), and diagnostic) of 9 case-finding interventions. We compared the model-estimated resources with scenarios of future resource availability and estimated the impact of interventions under these constraints. Without constraints, symptom screening in public health clinics and among persons receiving care for human immunodeficiency virus infection was predicted to lead to larger reductions in TB incidence (9.5% (2.5th-97.5th percentile range (PR), 8.6-12.2) and 14.5% (2.5th-97.5th PR, 12.2-16.3), respectively) than improved adherence to diagnostic guidelines (2.7%; 2.5th-97.5th PR, 1.6-4.1). However, symptom screening required large increases in resources, exceeding future HR capacity. Even under our most optimistic HR scenario, the reduction in TB incidence from clinic symptom screening was 0.2%-0.9%-less than that of improved adherence to diagnostic guidelines. Ignoring resource constraints may result in incorrect conclusions about an intervention's impact and may lead to suboptimal policy decisions. Models used for decision-making should consider resource constraints.

Identifiants

pubmed: 30824911
pii: 5368303
doi: 10.1093/aje/kwz038
pmc: PMC6545281
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1155-1164

Subventions

Organisme : Medical Research Council
ID : MR/P002404/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Références

Epidemiol Infect. 2008 Oct;136(10):1342-9
pubmed: 18177518
Bull World Health Organ. 2014 Feb 1;92(2):126-38
pubmed: 24623906
Lancet Glob Health. 2014 Oct;2(10):e581-91
pubmed: 25304634
Lancet Infect Dis. 2015 Sep;15(9):1066-1076
pubmed: 26112077
BMC Med. 2016 Mar 24;14:56
pubmed: 27012808
Lancet Glob Health. 2016 Nov;4(11):e816-e826
pubmed: 27720689
Soc Sci Med. 2016 Nov;169:66-76
pubmed: 27693973
PLoS One. 2015 Sep 18;10(9):e0138149
pubmed: 26383102
Int J Tuberc Lung Dis. 2011 Aug;15(8):996-1004
pubmed: 21740663
J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):e119-26
pubmed: 26966843
Lancet Glob Health. 2016 Nov;4(11):e806-e815
pubmed: 27720688
PLoS Med. 2017 Feb 21;14(2):e1002240
pubmed: 28222126
AIDS. 2016 Sep 24;30(15):2341-50
pubmed: 27367487
BMC Public Health. 2012 Oct 12;12:870
pubmed: 23061807
Int J Tuberc Lung Dis. 2013 May;17(5):608-14
pubmed: 23575325
PLoS Med. 2012;9(11):e1001347
pubmed: 23185139
Cost Eff Resour Alloc. 2018 Jul 30;16:27
pubmed: 30069166
Emerg Infect Dis. 2016 Mar;22(3):535-7
pubmed: 26891185
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9457-62
pubmed: 23690585
Int J Tuberc Lung Dis. 2018 Jun 1;22(6):606-613
pubmed: 29862943
Lancet Glob Health. 2015 Aug;3(8):e450-e457
pubmed: 26187490

Auteurs

Thomas Sumner (T)

TB Modelling Group, TB Centre, Centre for the Mathematical Modelling of Infectious Disease, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Fiammetta Bozzani (F)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Don Mudzengi (D)

Aurum Institute, Johannesburg, South Africa.

Piotr Hippner (P)

Aurum Institute, Johannesburg, South Africa.

Rein M Houben (RM)

TB Modelling Group, TB Centre, Centre for the Mathematical Modelling of Infectious Disease, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Vicky Cardenas (V)

Aurum Institute, Johannesburg, South Africa.

Anna Vassall (A)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Richard G White (RG)

TB Modelling Group, TB Centre, Centre for the Mathematical Modelling of Infectious Disease, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH